financetom
Business
financetom
/
Business
/
Why Is Smart Share Global Stock Surging Premarket On Monday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Is Smart Share Global Stock Surging Premarket On Monday?
Jan 6, 2025 4:03 AM

Smart Share Global Limited ( EM ) shares are trading higher premarket on Monday. The company disclosed that its board had received a preliminary non-binding proposal from a buyer group, including Trustar Capital and key executives, to take the company private.

The offer is for $0.625 per ordinary share or $1.25 per ADS in cash, representing a 74.8% premium to the stock’s last closing price.

The proposed deal values the company significantly above its recent trading averages.

Smart Share Global’s Board has established a special committee comprising of three independent directors to evaluate the buyout proposal.

The committee will appoint independent financial and legal advisors to support its review.

The board cautions that no decisions have been made regarding the proposal.

As of June 30, 2024, the company had cash and cash equivalents, restricted cash, and short-term investments of RMB3.2 billion ($440.9 million). 

Price Action: EM shares are up 52.4% at $1.09 premarket at the last check Monday.

Read Next:

S&P 500 Snaps Five-Day Losing Streak, Nvidia Surges: Investor Fear Eases, Greed Index Remains In ‘Fear’ Zone

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol Myers, Sanofi sued by Texas over Plavix
Bristol Myers, Sanofi sued by Texas over Plavix
Nov 20, 2025
Nov 20 (Reuters) - Texas Attorney General Ken Paxton sued Bristol Myers Squibb ( BMY ) and Sanofi, accusing the drugmakers of failing to disclose that Plavix, which is used to prevent blood clots, does not work effectively for many patients. Paxton said on Thursday the lack of disclosure caused patients to be prescribed a substantially inadequate or inappropriate medication,...
Keros Therapeutics Announces Final Results of Tender Offer
Keros Therapeutics Announces Final Results of Tender Offer
Nov 20, 2025
LEXINGTON, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ( KROS ) (“Keros” or the “Company”) , today announced the final results of its cash tender offer (the “Tender Offer”) to repurchase up to 10,950,165 shares of its common stock, at a fixed purchase price of $17.75 per share, for an aggregate purchase price of up to approximately...
Intuit expects quarterly revenue growth above estimates on strong financial tools demand
Intuit expects quarterly revenue growth above estimates on strong financial tools demand
Nov 20, 2025
(Reuters) -Intuit forecast second-quarter revenue growth above Wall Street estimates on Thursday, a sign of growing demand for its artificial intelligence-powered financial management tools. Shares of the company rose nearly 3% in extended trading. The company, which offers products such as tax-preparation software TurboTax, finance portal Credit Karma and accounting tool QuickBooks, is benefiting as customers increasingly seek personalized financial...
Stepan Company Completes Sale of Philippine Assets, Advancing Strategic Focus on Core Growth
Stepan Company Completes Sale of Philippine Assets, Advancing Strategic Focus on Core Growth
Nov 20, 2025
NORTHBROOK, Ill., Nov. 20, 2025 /PRNewswire/ -- Stepan Company today announced the successful closing, on November 14, 2025, of the sale of its subsidiary, Stepan Philippines Quaternaries, Inc. (SPQI), manufacturing assets located in Bauan, Batangas, Philippines to Masurf, Inc., a subsidiary of Musim Mas Holdings Pte. Ltd. This transaction fulfills SPQI's previously announced Asset Transfer Agreement, dated May 27, 2025, and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved